ROSIGLITAZONEPOTASSIUMSALT
- Product NameROSIGLITAZONEPOTASSIUMSALT
- CAS316371-84-3
- CBNumberCB21230682
- MFC18H19N3O3S.K
- MW396.53
- MDL NumberMFCD28143771
- MOL File316371-84-3.mol
- MSDS FileSDS
Chemical Properties
| storage temp. | Store at -20°C |
| solubility | Ethanol:2.0(Max Conc. mg/mL);5.06(Max Conc. mM) H2O:1.0(Max Conc. mg/mL);2.53(Max Conc. mM) |
| form | A crystalline solid |
| FDA UNII | 2V3E7D3089 |
ROSIGLITAZONEPOTASSIUMSALT Price
| Product number | Packaging | Price | Product description | Buy |
|---|---|---|---|---|
| Cayman Chemical 71742 | 5mg | $36 | Rosiglitazone (potassium salt) ≥98% |
Buy |
| Cayman Chemical 71742 | 10mg | $68 | Rosiglitazone (potassium salt) ≥98% |
Buy |
| Cayman Chemical 71742 | 50mg | $268 | Rosiglitazone (potassium salt) ≥98% |
Buy |
| Cayman Chemical 71742 | 100mg | $469 | Rosiglitazone (potassium salt) ≥98% |
Buy |
| ChemScene CS-0089698 | 5mg | $84 | Rosiglitazone potassium 99.13% |
Buy |
ROSIGLITAZONEPOTASSIUMSALT Chemical Properties,Usage,Production
Uses
Rosiglitazone (BRL 49653) potassium is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone potassium is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone potassium can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].in vivo
Rosiglitazone potassium (oral administration, 5 mg/kg, daily for 8 weeks) decreases the serum glucose in diabetic rats[5].
Rosiglitazone potassium (intraperitoneal injection, 3 mg/kg/day) ameliorates airway inflammation induced by cigarette smoke via inhibiting the M1 macrophage polarization by activating PPARγ and RXRα in male Wistar rats[6].
Rosiglitazone potassium (intraperitoneal injection, 10 mg/kg, once every 2 days) inhibits subcutaneous ovarian cancer growth in A2780 and SKOV3 mouse subcutaneous xenograft models[7].
| Animal Model: | Streptozotocin (STZ)-induced diabetic rats[5] |
| Dosage: | 5 mg/kg |
| Administration: | Oral administration, daily for 8 weeks. |
| Result: | Decreased IL-6, TNF-α, and VCAM-1 levels in diabetic group. Displayed lower levels of lipid peroxidation and NOx with an increase in aortic GSH and SOD levels compared to diabetic groups. |
| Animal Model: | Male Wistar rats[6] |
| Dosage: | 3 mg/kg/day |
| Administration: | Intraperitoneal injection, twice a day, 6 days per week for 12 consecutive weeks |
| Result: | Ameliorated emphysema, elevated PEF, and higher level of total cells, neutrophils and cytokines (TNF-α and IL-1β) induced by cigarette smoke (CS). Inhibited CS-induced M1 macrophage polarization and decreased the ratio of M1/M2. |
IC 50
PPARγ: 40 nM (Kd); PPARγ: 60 nM (EC50); TRPC5: 30 μM (EC50); TRPM3References
[1] Lehmann JM, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem. 1995 Jun 2;270(22):12953-6. DOI:10.1074/jbc.270.22.12953[2] Willson TM, et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem. 1996 Feb 2;39(3):665-8. DOI:10.1021/jm950395a
[3] Thouennon E, et al. Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection. J Neurochem. 2015 Aug;134(3):463-70. DOI:10.1111/jnc.13152
[4] Majeed Y, et al. Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels. Mol Pharmacol. 2011 Jun;79(6):1023-30. DOI:10.1124/mol.110.069922
[5] Ateyya H, et al. Beneficial effects of rosiglitazone and losartan combination in diabetic rats. Can J Physiol Pharmacol. 2018 Mar;96(3):215-220. DOI:10.1139/cjpp-2017-0332
[6] Haoshen Feng, et al. Rosiglitazone ameliorated airway inflammation induced by cigarette smoke via inhibiting the M1 macrophage polarization by activating PPARγ and RXRα. Int Immunopharmacol. 2021 Aug;97:107809. DOI:10.1016/j.intimp.2021.107809
[7] Zehua Wang, et al. Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib. Cancer Chemother Pharmacol. 2020 Feb;85(2):273-284. DOI:10.1007/s00280-019-04025-8
Preparation Products And Raw materials
ROSIGLITAZONEPOTASSIUMSALT Supplier
Global(27)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 400-6206333 13167063860 |
anhua.mao@aladdin-e.com | China | 29977 | 65 | |
| 0755-66853366 13670046396 |
orders@qcsrm.com | China | 18188 | 56 | |
| 021-65675885 18964387627 |
info@efebio.com | China | 9799 | 58 | |
| 18916372613 | yanzihan@shyuanye.com | China | 87240 | 60 | |
| 400-9205774 400-920-5774 |
sales@glpbio.cn | China | 6705 | 58 | |
| +86-400-002-6226 | sales@rrkchem.com | China | 57336 | 58 | |
| -- | info@bocsci.com | USA | 0 | 65 | |
| 18818260767 | sales@chemegen.com | China | 11123 | 58 | |
| 0513-68819626 15152877458 |
feiyubio@163.com | China | 4796 | 58 | |
| 4008200310 15002144251 |
marketing@tsbiochem.com | China | 24951 | 58 |
316371-84-3, ROSIGLITAZONEPOTASSIUMSALTRelated Search
PROMPT×
PROMPT
The WhatsApp is temporarily not supported in mainland China
The WhatsApp is temporarily not supported in mainland China
Cancel
Determine